London Research

Sep 3, 2024 | cell.com | Sun Yat-sen |London Research

KeywordsdifferentiationPICKLEnucleosome condensingH3K27me3 spreadingchromatin remodelingPolycomb silencing memoryLEC2seed germinationArabidopsisGet full text accessLog in, subscribe or purchase for full access. References1. Stewart-Morgan, K.R. ∙ Petryk, N. ∙ Groth, A. Chromatin replication and epigenetic cell memoryNat. Cell Biol. 2020; 22:361-3712. Yu, J.R. ∙ Lee, C.H. ∙ Oksuz, O. ... PRC2 is high maintenanceGenes Dev. 2019; 33:903-9353. Costa, S. ∙ Dean, C.

Jun 10, 2024 | bakersfield.com | London Research

LONDON, Ontario, June 10, 2024 (GLOBE NEWSWIRE) -- London Research & Pharmaceuticals presented notable pre-clinical data about its lead compound, LRP-661, also known as Cannabidiol Sulphate (CBDS), at the Seventeenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII) conference in Madrid, Spain, May 5th to May 8th, 2024. kAm{#!\ee`’D 52E2 9:89=:89ED :ED DFA6C:@C D276EJ[ 677:424J[ 3:@2G2:=23:=:EJ[ 2?5 !z :? >F=E:A=6 DA64:6D] uFCE96C>@C6[ {#!\ee`’D @C2= 7@C>F=2E:@?

Jun 10, 2024 | globenewswire.com | London Research

LONDON, Ontario, June 10, 2024 (GLOBE NEWSWIRE) -- London Research & Pharmaceuticals presented notable pre-clinical data about its lead compound, LRP-661, also known as Cannabidiol Sulphate (CBDS), at the Seventeenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII) conference in Madrid, Spain, May 5th to May 8th, 2024. LRP-661’s data highlights its superior safety, efficacy, bioavailability, and PK in multiple species.

May 24, 2024 | journals.plos.org | London Research |Ian Scott |Emine Kaplanoglu |Jessica Vickruck

Loading metrics Open Access Peer-reviewedResearch Article Citation: Kaplanoglu E, Scott IM, Vickruck J, Donly C (2024) Role of CYP9E2 and a long non-coding RNA gene in resistance to a spinosad insecticide in the Colorado potato beetle, Leptinotarsa decemlineata. PLoS ONE 19(5): e0304037.

Apr 15, 2024 | bakersfield.com | London Research

LONDON, Ontario, April 15, 2024 (GLOBE NEWSWIRE) -- London Research & Pharmaceuticals has recently publicized data about its lead compound LRP-661 or Cannabidiol sulphate (CBDS), highlighting its safety, efficacy, bioavailability, and predictable PK parameters. CBDS maintains improved oral formulation capabilities vs cannabidiol, including tablet and water-based solutions. kAm(96? 4@>A2C65 282:?DE E96 4FCC6?E=J 2G2:=23=6 @C2= D@=FE:@? @7 42??23:5:@= :? 2 D6D2>6 @:= DFDA6?D:@?[ rqs$ D9@HD ?@ 67764E @?